Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir

Background. The majority of patients receiving the platinum-based chemotherapy drug oxaliplatin develop peripheral neurotoxicity. Because this neurotoxicity involves ROS production, we investigated the efficacy of mangafodipir, a molecule that has antioxidant properties and is approved for use as an...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Coriat, Romain, Alexandre, Jérôme, Nicco, Carole, Quinquis, Laurent, Benoit, Evelyne, Chéreau, Christiane, Lemaréchal, Hervé, Mir, Olivier, Borderie, Didier, Tréluyer, Jean-Marc, Weill, Bernard, Coste, Joel, Goldwasser, François, Batteux, Frédéric
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2013
Matèries:
Clinical Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3871222/
https://ncbi.nlm.nih.gov/pubmed/24355920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI68730
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars